1. Depression and recovery of IL-17A secretion in mitogen responses in patients with active tuberculosis-a prospective observational study
   Jia-Yih Feng et al, 2021, Journal of the Formosan Medical Association CrossRef
2. RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
   Shuhui Zhang et al, 2020, Frontiers in Pharmacology CrossRef
3. PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis
   Sheng-Wei Pan et al, 2022, International Journal of Molecular Sciences CrossRef
4. Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
   P. Hofman et al, 2019, Annals of Oncology CrossRef
5. Sex difference in the expression of PD-1 of non-small cell lung cancer
   Yong Gu et al, 2022, Frontiers in Immunology CrossRef
6. PD-L1 induces macrophage polarization toward the M2 phenotype via Erk/Akt/mTOR
   Yi Wei et al, 2021, Experimental Cell Research CrossRef
7. The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte
   Baojuan Han et al, 2021, Cancer Immunology, Immunotherapy CrossRef
8. Plasma immune profiling combined with machine learning contributes to diagnosis and prognosis of active pulmonary tuberculosis
   Fusheng Yao et al, 2024, Emerging Microbes & Infections CrossRef
9. PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV
   Wegene Tamene et al, 2021, PLOS ONE CrossRef